Sharon Benzeno Insider Trades & Stock Holdings

Chief Commercial Ofc Imm Med · Adaptive Biotechnologies Corporation · Latest filing Jun 29, 2026

Sharon Benzeno, Chief Commercial Ofc Imm Med at Adaptive Biotechnologies Corporation has 3 Form 4 trades on file since Jun 26, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($231.71K), net -$231.71K. Latest filing: disposed of 103.30K shares of $ADPT on Jun 29, 2026.

Trades on file

3

Open-market bought

$0

Open-market sold

$231.71K

Net open-market

-$231.71K

Latest filing

Jun 29, 2026

All insider trades by Sharon Benzeno

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 29, 2026	$ADPT	Sell (Option exercise)	103.30K	$0	—			+0.5%	+5.4%		Chief Commercial Ofc Imm Med		—
Jun 29, 2026	$ADPT	Buy (Option exercise)	103.30K	$7.28	$751.61K			+0.5%	+5.4%		Chief Commercial Ofc Imm Med		Read
Jun 26, 2026	$ADPT	Sell (Open-market sale) 10b5-1	11.03K	$21	$231.71K			+2.6%	+7.5%		Chief Commercial Ofc Imm Med		Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Sharon Benzeno traded

• $ADPT

Frequently asked questions

Has Sharon Benzeno been buying or selling stock?

Sharon Benzeno has 0 open-market purchases and 1 open-market sale on file, net -$231.71K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Sharon Benzeno's latest insider trade?

disposed of 103.30K shares of $ADPT on Jun 29, 2026.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.